Cizzle Biotechnology Announces Strategic Agreement with the Behnke Group to Enhance U.S. Market Presence
LONDON, June 16, 2022 /PRNewswire/ — Cizzle Biotechnology Holdings PLC, the UK based diagnostics developer, is pleased to announce that it has entered into an agreement with the Behnke Group, a Texas-based healthcare consulting firm with decades of experience collaborating with…
Comments Off on Cizzle Biotechnology Announces Strategic Agreement with the Behnke Group to Enhance U.S. Market Presence